Pharsight

LYSANDO AG patents facing oppositions

Top patents of LYSANDO AG facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3129044B1 07 Sep, 2022 Peptidoglycan hydrolase for use in the treatment of chronic bacterial infections Apr, 2035 2